Efficacy and safety of antiarrhythmic drugs for pharmacological cardioversion of atrial fibrillation depending on gender: a subanalysis of CANT II Study

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Cardioversion, antiarrhythmics and antithrombotic management of atrial fibrillation Antiarrhythmic Drug Treatment ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by